0001850902-24-000009.txt : 20240227 0001850902-24-000009.hdr.sgml : 20240227 20240227162138 ACCESSION NUMBER: 0001850902-24-000009 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220815 FILED AS OF DATE: 20240227 DATE AS OF CHANGE: 20240227 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Grossman Paul David CENTRAL INDEX KEY: 0001401768 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40538 FILM NUMBER: 24687112 MAIL ADDRESS: STREET 1: 1600 FARADAY AVENUE CITY: CARLSBAD STATE: CA ZIP: 92008 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alpha Teknova, Inc. CENTRAL INDEX KEY: 0001850902 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 943368109 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2451 BERT DRIVE CITY: HOLLISTER STATE: CA ZIP: 95023 BUSINESS PHONE: 8316371100 MAIL ADDRESS: STREET 1: 2451 BERT DRIVE CITY: HOLLISTER STATE: CA ZIP: 95023 4 1 edgardoc.xml PRIMARY DOCUMENT X0508 4 2022-08-15 0 0001850902 Alpha Teknova, Inc. TKNO 0001401768 Grossman Paul David 300 MONTGOMERY STREET SUITE 1130 SAN FRANCISCO CA 94104 1 0 0 0 0 Common Stock 2022-08-15 4 P 0 4826 5.1478 A 4826 D Common Stock 2022-08-16 4 P 0 4386 5.6226 A 9212 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.10 to $5.1765, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.49 to $5.6822, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote to this Form 4. By: Damon A. Terrill For: Paul David Grossman 2024-02-27